http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 14 Jul 2026 16:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+MAIDA+ANTHONY+E+III/26768128.html si-local-file:///var/storage/secattach/20260714/26768128.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+MAIDA+ANTHONY+E+III/26768128.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+MAIDA+ANTHONY+E+III/26768128.html si-local-file:///var/storage/secattach/20260714/26768128.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+MAIDA+ANTHONY+E+III/26768128.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Saund+Saran/26768129.html si-local-file:///var/storage/secattach/20260714/26768129.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Saund+Saran/26768129.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Saund+Saran/26768129.html si-local-file:///var/storage/secattach/20260714/26768129.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Saund+Saran/26768129.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Shah+Amit+B./26768131.html si-local-file:///var/storage/secattach/20260714/26768131.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Shah+Amit+B./26768131.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Shah+Amit+B./26768131.html si-local-file:///var/storage/secattach/20260714/26768131.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Shah+Amit+B./26768131.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Trieu+Vuong/26768132.html si-local-file:///var/storage/secattach/20260714/26768132.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Trieu+Vuong/26768132.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Trieu+Vuong/26768132.html si-local-file:///var/storage/secattach/20260714/26768132.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10++Filed+by%3A+Trieu+Vuong/26768132.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10/26768133.html si-local-file:///var/storage/secattach/20260714/26768133.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10/26768133.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10/26768133.html si-local-file:///var/storage/secattach/20260714/26768133.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+10/26768133.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+13/26768134.html si-local-file:///var/storage/secattach/20260714/26768134.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+13/26768134.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+13/26768134.html si-local-file:///var/storage/secattach/20260714/26768134.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+13/26768134.html Tue, 14 Jul 2026 16:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+01++Filed+by%3A+Trieu+Vuong/26726921.html si-local-file:///var/storage/secattach/20260702/26726921.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+01++Filed+by%3A+Trieu+Vuong/26726921.html Thu, 02 Jul 2026 15:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+01++Filed+by%3A+Trieu+Vuong/26726921.html si-local-file:///var/storage/secattach/20260702/26726921.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jul+01++Filed+by%3A+Trieu+Vuong/26726921.html Thu, 02 Jul 2026 15:00:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+23/26707604.html si-local-file:///var/storage/secattach/20260629/26707604.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+23/26707604.html Mon, 29 Jun 2026 17:15:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+23/26707604.html si-local-file:///var/storage/secattach/20260629/26707604.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+23/26707604.html Mon, 29 Jun 2026 17:15:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Trieu+Vuong/26686925.html si-local-file:///var/storage/secattach/20260624/26686925.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Trieu+Vuong/26686925.html Wed, 24 Jun 2026 20:37:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Trieu+Vuong/26686925.html si-local-file:///var/storage/secattach/20260624/26686925.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Trieu+Vuong/26686925.html Wed, 24 Jun 2026 20:37:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Shah+Amit+B./26673527.html si-local-file:///var/storage/secattach/20260622/26673527.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Shah+Amit+B./26673527.html Mon, 22 Jun 2026 16:30:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Shah+Amit+B./26673527.html si-local-file:///var/storage/secattach/20260622/26673527.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+22++Filed+by%3A+Shah+Amit+B./26673527.html Mon, 22 Jun 2026 16:30:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+15++Filed+by%3A+Trieu+Vuong/26661398.html si-local-file:///var/storage/secattach/20260617/26661398.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+15++Filed+by%3A+Trieu+Vuong/26661398.html Wed, 17 Jun 2026 19:34:00 -0400 O.01670430 OTLC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+15++Filed+by%3A+Trieu+Vuong/26661398.html si-local-file:///var/storage/secattach/20260617/26661398.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncotelic+Therapeutics%2C+++For%3A+Jun+15++Filed+by%3A+Trieu+Vuong/26661398.html Wed, 17 Jun 2026 19:34:00 -0400 O.01670430 OTLC http://www.streetinsider.com/Press+Releases/Oncotelic+Therapeutics+Files+First+Quarter+2026+Financial+Results+and+Strategic+Progress/26500417.html <p align="justify">Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage biotechnology company focused on oncology, AI-enabled drug development, and advanced drug delivery platforms, yesterday filed financial results for the quarter ended March 31, 2026 through its Quarterly Report on Form 10-Q, and is providing a corporate update highlighting progress across its therapeutic and platform initiatives.</p> <p align="justify">“We believe the first quarter of 2026 continues to provide validation for the strategic value of our diversified biotechnology platform,” said Dr. Vuong Trieu, CEO of Oncotelic. “During the quarter, http://www.streetinsider.com/Press+Releases/Oncotelic+Therapeutics+Files+First+Quarter+2026+Financial+Results+and+Strategic+Progress/26500417.html Fri, 15 May 2026 09:00:00 -0400 A.21139722 O.01670430 OTLC http://www.streetinsider.com/Press+Releases/Oncotelic+Therapeutics+Files+First+Quarter+2026+Financial+Results+and+Strategic+Progress/26500417.html <p align="justify">Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage biotechnology company focused on oncology, AI-enabled drug development, and advanced drug delivery platforms, yesterday filed financial results for the quarter ended March 31, 2026 through its Quarterly Report on Form 10-Q, and is providing a corporate update highlighting progress across its therapeutic and platform initiatives.</p> <p align="justify">“We believe the first quarter of 2026 continues to provide validation for the strategic value of our diversified biotechnology platform,” said Dr. Vuong Trieu, CEO of Oncotelic. “During the quarter, http://www.streetinsider.com/Press+Releases/Oncotelic+Therapeutics+Files+First+Quarter+2026+Financial+Results+and+Strategic+Progress/26500417.html Fri, 15 May 2026 09:00:00 -0400 A.21139722 O.01670430 OTLC http://www.streetinsider.com/Press+Releases/Oncotelic+Therapeutics+Files+First+Quarter+2026+Financial+Results+and+Strategic+Progress/26500417.html <p align="justify">Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage biotechnology company focused on oncology, AI-enabled drug development, and advanced drug delivery platforms, yesterday filed financial results for the quarter ended March 31, 2026 through its Quarterly Report on Form 10-Q, and is providing a corporate update highlighting progress across its therapeutic and platform initiatives.</p> <p align="justify">“We believe the first quarter of 2026 continues to provide validation for the strategic value of our diversified biotechnology platform,” said Dr. Vuong Trieu, CEO of Oncotelic. “During the quarter, http://www.streetinsider.com/Press+Releases/Oncotelic+Therapeutics+Files+First+Quarter+2026+Financial+Results+and+Strategic+Progress/26500417.html Fri, 15 May 2026 09:00:00 -0400 A.21139722 O.01670430 OTLC